Science & Technology
A Uniquely Scalable Platform for Sequencing Tens of Millions of Single Cells from Complex Clinical Samples with a Streamlined Workflow
Department of Health and Human Services — National Institutes of Health
Opportunity #: 2R44GM149003-02
Award Ceiling
$938K
Award Floor
$938K
Close Date
Jul 31, 2027
503 days leftTotal Funding
$938K
Expected Awards
1
Posted Date
Aug 15, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-2R44GM149003-02
Description
SBIR Phase Phase II award: "A Uniquely Scalable Platform for Sequencing Tens of Millions of Single Cells from Complex Clinical Samples with a Streamlined Workflow" awarded to SANSIMEON INC in WILMINGTON, Delaware. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $938,335. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.